Avantium Holding BV operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Avantium Holding BV with three other
miscellaneous service companies in Europe:
Newron Pharmaceuticals Spa
sales of 13.29 million Euro [US$16.32 million]
of which 100%
(14.31 million Euro [US$17.57 million]
based in the United Kingdom
(£10.74 million [US$15.04 million]
During the year ended December of 2017, sales at
Avantium Holding BV were 12.65 million Euro (US$15.54 million).
increase of 20.6%
versus 2016, when the company's sales were 10.49 million Euro.
This was the third consecutive year of growth at Avantium Holding BV.
Sales of Catalysis saw an increase
22.1% in 2017, from
10.24 million Euro to 12.50 million Euro.
Not all segments of Avantium Holding BV experienced an increase in sales in 2017:
sales of Yxy fell 54.9% to 147,000.00 Euro.
(However, this segment's sales were only a very small portion of the company's overall sales).